Trial
NCT06963216
A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Kedrion S.p.A.
Collaborators
—
Condition
Acquired Factor X Deficiency
Intervention
Coagadex(R)
Why stopped
Study was discontinued for non-safety reasons and the rapidly evolving treatment landscape for AL amyloidosis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-29